CD8A and neoplasm: Upon in vitro restimulation, CD8+ T cells from the MEKi-treated tumors exhibited more pronounced effector characteristics than T cells from control tumors measured by IFNγ production, supporting the notion of MEK inhibition leading to the presence of a more potent tumor-infiltrating effector T cell population (11).